Toshihiko Kitahara

Speciation of arsenic trioxide penetrates into cerebrospinal fluid in patients with acute promyelocytic leukemia

Toru Kiguchi, Yuta Yoshino, Bo Yuan et al. · Leukemia Research · 2009 · 53 citations

Pharmacy, Oncology, Toxicology +9

Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with nilotinib against BCR-ABL-positive leukemia cells involves the ABL kinase domain mutation

Seiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka et al. · Cancer Biology & Therapy · 2013 · 42 citations · Full text

Medicine, Oncology, Pharmacology +16

Fetal hemoglobin level predicts lower-risk myelodysplastic syndrome

Ryujiro Hara, Toshihiko Kitahara, Hiroki Numata et al. · International Journal of Hematology · 2022 · 16 citations

Medicine, Hematology, Obstetrics +12

Combining the ABL1 Kinase Inhibitor Ponatinib and the Histone Deacetylase Inhibitor Vorinostat: A Potential Treatment for BCR-ABL-Positive Leukemia

Seiichi Okabe, Tetsuzo Tauchi, Shinya Kimura et al. · PLoS ONE · 2014 · 15 citations · Full text

Medicine, Oncology, Pharmacology +13

Application of pluronic F68 for aqueous two-phase extraction of proteins.

Toshihiko Kitahara, Masamichi Kamihira, Hiroshi Takeuchi · JOURNAL OF CHEMICAL ENGINEERING OF JAPAN · 1993 · 12 citations · Full text

Pharmacy, Biochemistry, Biotechnology +17